Allergopharma Joachim Ganzer KG

Heska Announces Q4 and Annual 2007 Results.
PR Newswire; 2/26/2008; 3239 words; ...allergens and the genes that encode them to Allergopharma Joachim Ganzer KG (the "Allergopharma Portfolio") in December 2006. For 2007...million in licensing revenue related to the Allergopharma Portfolio, including revenue from the amortization...

Morning Alert for Heska Corp.
M2 Presswire; 4/17/2007; 1419 words; ...worldwide patent portfolio covering a number of major allergens and the genes that encode them to Allergopharma Joachim Ganzer KG (the "Allergopharma Portfolio") in December 2006. As part of the agreement, Heska has exclusively licensed veterinary...

Heska Corp. Reports Financial Results.
M2 Presswire; 4/17/2007; 1487 words; ...worldwide patent portfolio covering a number of major allergens and the genes that encode them to Allergopharma Joachim Ganzer KG (the "Allergopharma Portfolio") in December 2006. As part of the agreement, Heska has exclusively licensed veterinary...

Heska Announces Q4 and Annual 2006 Results.
PR Newswire; 3/12/2007; 2166 words; ...allergens and the genes that encode them to Allergopharma Joachim Ganzer KG (the "Allergopharma Portfolio") in December 2006. As part...recognized upon completion of the sale of the Allergopharma Portfolio. For 2006, research, development...

Heska Announces Sale of Allergy Patent Portfolio.
PR Newswire; 1/22/2007; 869 words; ...allergens and the genes that encode them to Allergopharma Joachim Ganzer KG ("Allergopharma") for an undisclosed sum. As part of the...leader in the allergy market," commented Joachim Ganzer, Managing Partner of Allergopharma...